| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 07/14/2004 | EP1437346A1 Benzamide derivatives useful as cell differentiation inducers |
| 07/14/2004 | EP1437344A1 Benzene derivatives,process for preparing the same and use thereof |
| 07/14/2004 | EP1437342A2 Fluorinating reactants and process for their preparation |
| 07/14/2004 | EP1436273A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof |
| 07/14/2004 | EP1436255A1 Novel compounds and compositions as cathepsin inhibitors |
| 07/14/2004 | EP1436249A2 Muscarinic agonists |
| 07/14/2004 | EP1435956A2 Therapeutic combinations for cardiovascular and inflammatory indications |
| 07/14/2004 | EP1435955A2 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 07/14/2004 | EP1435944A1 4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
| 07/14/2004 | EP1435943A2 Use of 2-oxo-1-pyrrolidine derivatives for the preparation of a drug for treating dyskinesia |
| 07/14/2004 | EP1435934A1 5'-acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1414392A4 Primary intermediates for oxidative coloration of hair |
| 07/14/2004 | EP1228067B1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 07/14/2004 | EP1214321B1 Process for production of naphthyridine-3-carboxylic acid derivatives |
| 07/14/2004 | EP1144368B1 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
| 07/14/2004 | EP0901468B1 Preparation of lactams from aliphatic alpha,omega-dinitriles |
| 07/14/2004 | CN1512991A 吡咯烷双环化合物 Pyrrolidine bicyclic compound |
| 07/14/2004 | CN1512986A Substituted anilide derivatives, intermediates thereof, agricultural and horticultural chemicals and their usage |
| 07/14/2004 | CN1512983A Compounds and compositions as cathepsins inhibitors |
| 07/14/2004 | CN1512982A Novel polyamine analogues as therapeutic and diagnostic agents |
| 07/14/2004 | CN1512880A Novel compounds and compositions as cathepsin inhibitors |
| 07/14/2004 | CN1157391C Method and intermediate for preparing is-a-oxazole formylamine and its analogue |
| 07/14/2004 | CN1157374C Process for preparation of amorphous atorvastatin calcium |
| 07/14/2004 | CN1157365C Monoamine reuptake inhibitors for treatment of CNS disorders |
| 07/13/2004 | US6762304 Bis-transition metal catalysts having d2 symmetry |
| 07/13/2004 | US6762187 Heterocyclic nitrogen compounds used as enzyme inhibitors for prophylaxis of human immunodeficiency virus(hiv) |
| 07/13/2004 | US6762176 Inhibiting no-synthase enzymes producing nitrogen monoxide and/or trapping reactive forms of oxygen; inhibit lipidic peroxidation |
| 07/08/2004 | WO2004056777A1 Microsomal triglyceride transfer protein inhibitors |
| 07/08/2004 | WO2004056767A1 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists |
| 07/08/2004 | WO2004056766A1 Inhibitors of tace |
| 07/08/2004 | WO2004056764A1 Aromatic derivatives as hiv aspartyl protease inhibitors |
| 07/08/2004 | WO2004056755A2 Compounds for the inhibition of non-proteolytic enzymes |
| 07/08/2004 | WO2004056751A1 Antibacterial agents |
| 07/08/2004 | WO2004056745A2 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 07/08/2004 | WO2004056744A1 Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors |
| 07/08/2004 | WO2004056727A2 Process of making chalcone derivatives |
| 07/08/2004 | WO2004051217A3 Process for synthesis bis-aryl diamidoxime compounds |
| 07/08/2004 | WO2004048352A3 2-cyanopyrrolidines and their analogues as dpp-iv inhibitors |
| 07/08/2004 | WO2004037171A3 Mitotic kinesin inhibitors |
| 07/08/2004 | WO2004009017A3 Modulators of the glucocorticoid receptor and method |
| 07/08/2004 | US20040133015 Suspension crystallization is used and the resulting remaining melt or suspension crystals that have been molten once again and separated are subjected to a mechanical separation before undergoing subsequent purification by crystallization |
| 07/08/2004 | US20040133008 Amide compounds |
| 07/08/2004 | US20040132809 Cell adhesion inhibitors |
| 07/08/2004 | US20040132801 Therapeutic proline derivatives |
| 07/08/2004 | US20040132782 Aspartyl protease inhibitors |
| 07/08/2004 | US20040132758 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders |
| 07/08/2004 | US20040132745 carbamoyl-substituted aromatics, e.g., N-(butylcarbamoyl-phenyl-methyl)-6-[(4'-trifluoromethyl-biphenyl-2-carbonyl)-amino]-nicotinamide; treating hypercholesterolemia, hypertriglyceridemia, pancreatitis, obesity and diabetic conditions |
| 07/08/2004 | US20040132722 Glycoprotein-mediated MDR |
| 07/08/2004 | US20040132713 Fluorinated cyclic amides as dipeptidyl peptidase IV inhibitors |
| 07/08/2004 | US20040128899 Firing system for a firearm |
| 07/08/2004 | DE4328838B4 Verfahren zur Herstellung von cyclischen N-Azidosulfonylarylimiden A process for producing cyclic N-Azidosulfonylarylimiden |
| 07/08/2004 | DE10257358A1 Substituierte Pyrrole Substituted pyrroles |
| 07/08/2004 | CA2508621A1 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 07/08/2004 | CA2505604A1 Microsomal triglyceride transfer protein inhibitors |
| 07/07/2004 | EP1435353A1 Novel heterocyclic compound and anti-inflammatory agent |
| 07/07/2004 | EP1435352A2 9-[(Substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines |
| 07/07/2004 | EP1434775A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists |
| 07/07/2004 | EP1434765A1 Substituted piperidines with selective binding to histamine h3-receptor |
| 07/07/2004 | EP1434580A2 Allylamides useful in the treatment of alzheimer's disease |
| 07/07/2004 | EP1434577A1 Pyrrolidinone derivatives |
| 07/07/2004 | EP1237864B1 Process for the preparation of amorphous atorvastatin |
| 07/07/2004 | EP1212321B1 Intermediates for the production of naphthyridine-3-carboxylic acid derivatives |
| 07/07/2004 | EP1071670B1 Novel diphenyl-substituted 5-ring-heterocycles, method for producing them and their use as medicaments |
| 07/07/2004 | CN1511152A N-formyl hydroxylamine compounds as PDF inhibitor |
| 07/07/2004 | CN1156834C 光学记录介质 The optical recording medium |
| 07/07/2004 | CN1156444C Optical breaking process of dl-trans-phenyl-5-0-chlorobenzyl pyrrolidone-2 |
| 07/07/2004 | CN1156216C Compostion for keeping away rermin |
| 07/06/2004 | US6759554 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/06/2004 | US6759548 Dialkyl-halogenophenyl-substituted ketoenols |
| 07/06/2004 | US6759511 Compound used as an amino-protecting group, process for preparing the same, and synthetic method of a peptide using the same |
| 07/06/2004 | US6759430 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 07/06/2004 | US6759429 Having transforming growth factor- beta inhibitory activity and being useful as fibrosis inhibitors for organs or tissues |
| 07/06/2004 | US6759412 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis |
| 07/01/2004 | WO2004054982A1 Biphenylcarboxamides |
| 07/01/2004 | WO2004054973A2 Piperidine and pyrrolidine derivatives as antagonists of histamine h3 receptor |
| 07/01/2004 | WO2004054971A1 Method for production of the r,r (or s,s) configuration of glycopyrronium stereoisomers |
| 07/01/2004 | WO2004054970A1 Asimadoline derivatives comprising covalently bonded acids |
| 07/01/2004 | WO2004054581A2 Cyclohexyl compounds as ccr5 antagonists |
| 07/01/2004 | WO2004043912A3 Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors |
| 07/01/2004 | WO2004024681A3 Novel compounds comprising a thiocarbonyl-sulfanyl group, which can be used for the radical synthesis of alpha-perfluoroalkylamines |
| 07/01/2004 | WO2004018644A3 HETEROGENEOUS FOLDAMERS CONTAINING α, β, AND/OR Ϝ-AMINO ACIDS |
| 07/01/2004 | WO2004000802A3 Scaffolded maleimide clusters for multivalent peptide assembly |
| 07/01/2004 | WO2003080577A3 Amidoacetonitrile compounds |
| 07/01/2004 | US20040127721 Process for the synthesis of bis-aryl diamidoxime compounds |
| 07/01/2004 | US20040127710 Red luminescent compound and organic electroluminescent device using the same |
| 07/01/2004 | US20040127705 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action |
| 07/01/2004 | US20040127703 optically active 3-amino-pyrrolidine derivatives can be safely manufactured in high yield on a technical scale by replacing allylamine with hydroxylamine or its acid addition salt |
| 07/01/2004 | US20040127658 Productivity catalysts and microstructure control |
| 07/01/2004 | US20040127547 Prodigiosin composition for the treatment of rheumatic arthritis |
| 07/01/2004 | US20040127494 Sulfur compounds such as (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide, used for prophylaxis of neurodegenarative disorders such as Alzheimer's Disease and Down's Syndrome |
| 07/01/2004 | US20040127464 potent, selective and safe inhibitors of the Ca2+-activated potassium channel |
| 07/01/2004 | US20040127365 Arylphenyl-substituted cyclic ketoenols |
| 07/01/2004 | US20040123401 Colorfastness; mixture containing oxidation base and coupler |
| 07/01/2004 | DE10261131A1 Substituierte 5-Aminomethyl-1H-pyrrol-2-carbonsäureamide Substituted 5-aminomethyl-1H-pyrrole-2-carboxylic acid |
| 07/01/2004 | DE10259245A1 Derivate des Asimadolins mit kovalent gebundenen Säuren Derivatives of Asimadolins with covalently bound acids |
| 06/30/2004 | EP1433781A1 Pyrrolidine carboxylic acid derivatives |
| 06/30/2004 | EP1433779A1 Use of nitriles as inhibitors of non-proteolytic enzymes |
| 06/30/2004 | EP1433778A1 Use of nitriles as rotamase inhibitors |
| 06/30/2004 | EP1432687A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 06/30/2004 | EP1432679A1 Preparation and use of pyrrole derivatives for treating obesity |